As the real world increasingly adopts “artificial intelligence”, Companion Animals segment is leveraging AI technologies for varied usages including serving as “At-Home’ Health Platform.
Wonder Dog Health, Inc. has launched Wonderdog, a preventive health platform for dogs that pairs at-home blood draws with an AI-powered health companion, aiming to catch disease indicators months or years before symptoms appear. The Hermosa Beach, California-based startup is currently operating in Los Angeles and New York City, with additional cities planned.
Launch at a Glance
| Detail | Figure |
|---|---|
| Company | Wonder Dog Health, Inc. |
| Founded | 2026 |
| Headquarters | Hermosa Beach, California |
| Current service areas | Los Angeles, New York City |
| Funding raised to date | $5 million (pre-seed) |
| Chief Medical Officer | Dr. Evan Antin, DVM |
| AI Health Companion cost | Free (limited time) |
| At-home blood draw membership (1 draw/year) | $249 |
| At-home blood draw membership (2 draws/year) | $449 |
| Biomarkers tested | 40+ |
| Conditions with tracked early indicators | 14 named conditions |
| Laboratory partner | Largest veterinary reference laboratory in North America (unnamed) |
How the Platform Works
Wonderdog’s model starts with a telehealth consultation, where a licensed veterinarian reviews the dog’s existing records, prior bloodwork, diet, and known conditions. A certified veterinary technician then visits the dog’s home to perform a short blood draw covering more than 40 biomarkers, grouped into five categories: Blood Health (15 markers), Organ Function (14 markers), Metabolic Health (7 markers), Hormones and Endocrine (6 markers), and Inflammation and Immunity (3 markers).
Results are reviewed by a veterinarian and fed into what the company calls a Health Score, a composite reading built from the panel results and the individual dog’s own established baseline. The company’s AI Health Companion — accessible through a mobile app — is designed to answer owner questions specific to their own dog’s history rather than general canine health information, and to flag meaningful shifts in the data as they occur.
Wonderdog says its panel is designed to surface early indicators of 14 conditions: diabetes, lymphoma, kidney disease, Lyme disease, heart disease, pancreatitis, hemangiosarcoma, cancer, immune disease, liver disease, sepsis, inflammatory disease, Addison’s disease, and heartworm.
Company Positioning and Leadership
Dr. Evan Antin, a veterinarian with more than a decade of clinical experience, serves as Wonderdog’s Chief Medical Officer. In materials describing the panel’s design, Antin said the company “built this panel for uncompromising depth” and that there were “no shortcuts” in its development. The company also says it has partnered with the largest veterinary reference laboratory in North America to process testing, though it does not name the lab directly in its public materials.
Wonder Dog Health frames the service as a complement to, rather than a replacement for, traditional veterinary care. The company describes its role as filling the gap between a dog’s one or two annual vet visits, with the goal of giving both owners and veterinarians a fuller data picture — including synced records and tracked trends — by the time of the next appointment.
The company cites an internal claim that roughly one in five healthy-appearing dogs is hiding a disease that will affect its lifespan, underpinning its broader pitch that disease caught before clinical symptoms appear gives owners meaningfully more time to intervene. A customer testimonial included in the company’s marketing materials, attributed to a member named Laura Patton, describes a case in which the panel flagged a dog’s shifting kidney values before any outward symptoms were visible.
